Processing

Please wait...

Settings

Settings

1. WO2020004014 - MYOGENIC DIFFERENTIATION-PROMOTING ACTIVITIES OF ERGOTHIONEINE, ASCORBIC ACID 2-GLUCOSIDE, ASCORBIC ACID, AND COMBINATION THEREOF

Publication Number WO/2020/004014
Publication Date 02.01.2020
International Application No. PCT/JP2019/023114
International Filing Date 11.06.2019
IPC
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
07
Animal cells or tissues
071
Vertebrate cells or tissues, e.g. human cells or tissues
077
Mesenchymal cells, e.g. bone cells, cartilage cells, marrow stromal cells, fat cells or muscle cells
[IPC code unknown for A23L 33/175]
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4164
1,3-Diazoles
4172
Imidazole-alkanecarboxylic acids, e.g. histidine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
21
Drugs for disorders of the muscular or neuromuscular system
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
1
Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
C12N 5/077 (2010.01)
A23L 33/175 (2016.01)
A61K 31/4172 (2006.01)
A61P 21/00 (2006.01)
C12N 1/00 (2006.01)
CPC
A23L 33/175
A61K 31/4172
A61P 21/00
C12N 1/00
Applicants
  • 長瀬産業株式会社 NAGASE & CO., LTD. [JP/JP]; 大阪府大阪市西区新町1丁目1番17号 1-1-17, Shinmachi, Nishi-ku, Osaka-shi, Osaka 5508668, JP
Inventors
  • 小坂 邦男 KOSAKA, Kunio; JP
Agents
  • 山尾 憲人 YAMAO, Norihito; JP
  • 冨田 憲史 TOMITA, Kenji; JP
Priority Data
2018-12461329.06.2018JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) MYOGENIC DIFFERENTIATION-PROMOTING ACTIVITIES OF ERGOTHIONEINE, ASCORBIC ACID 2-GLUCOSIDE, ASCORBIC ACID, AND COMBINATION THEREOF
(FR) ACTIVITÉS DE L'ERGOTHIONÉINE, DE L'ACIDE ASCORBIQUE 2-GLUCOSIDE, DE L'ACIDE ASCORBIQUE, ET DE LEUR COMBINAISON FAVORISANT LA DIFFÉRENCIATION MYOGÉNIQUE
(JA) エルゴチオネイン、アスコルビン酸2-グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用
Abstract
(EN)
The present invention provides: a culture medium and a culture medium additive which are for myogenic differentiation promotion and which contain ergothioneine, ascorbic acid 2-glucoside, ascorbic acid, or a combination thereof; a kit; and a pharmaceutical composition and food and drink for myogenic differentiation promotion.
(FR)
La présente invention concerne : un milieu de culture et un additif de milieu de culture qui sont destinés à favoriser la différenciation myogénique et qui contiennent de l'ergothionéine, de l'acide ascorbique 2-glucoside, de l'acide ascorbique ou une combinaison de ceux-ci ; un kit ; et une composition pharmaceutique et un aliment et une boisson pour favoriser la différenciation myogénique.
(JA)
本発明は、エルゴチオネイン、アスコルビン酸2-グルコシド、アスコルビン酸、およびそれらの組み合わせを含む筋分化促進用培地および培地添加剤、キット、ならびに筋分化促進用医薬組成物および飲食物を提供する。
Latest bibliographic data on file with the International Bureau